FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083078 [Registered on: 21/03/2025] Trial Registered Prospectively
Last Modified On: 20/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   TO STUDY THE NUMBER OF CHILDREN AFFECTED WITH OBESITY AND EFFECT OF AYURVEDIC COMPOUND AMRITADI GUGGULU AND RUKSHA UDVARTANA REDUCED THE WEIGHT IN CHILDREN.ALSO TO STUDY THE VARIOUS FACTORS RESPONSIBLE FOR THE WEIGHT GAIN IN CHILDREN. 
Scientific Title of Study   A Comparative Clinical Study to evaluate the efficacy of Amritadi Guggulu and Ruksha Udvartana in the Management of Sthaulya W.S.R. Obesity in children. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashok Mundotiya 
Designation  pg scholar 
Affiliation  madan mohan malviya govt collage 
Address  PG DEPARTMENT OF KAUMARBHRTYA madan mohan malviya govt ayurveda collage radaji circle ambamata udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  08824119924  
Fax    
Email  ashokmundotiya91926@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashok Mundotiya 
Designation  pg scholar 
Affiliation  madan mohan malviya govt collage 
Address  PG DEPARTMENT OF KAUMARBHRTYA madan mohan malviya govt ayurveda collage radaji circle ambamata udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  08824119924  
Fax    
Email  ashokmundotiya91926@gmail.com  
 
Details of Contact Person
Public Query
 
Name  prof ram kumar 
Designation  professor & HOD 
Affiliation  madan mohan malviya govt ayurveda collage radaji circle ambamata udaipur 
Address  PG DEPARTMENT OF KAUMARBHRTYA madan mohan malviya govt ayurveda collage radaji circle ambamata udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8005857838  
Fax    
Email  drbhamuramkumar@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Govt Ayurveda Collage Udaipur, Rajasthan Pin Code - 313001 
 
Primary Sponsor  
Name  Madan Mohan Malviya Govt Ayurveda Collage Udaipur 
Address  PG Department of Kaumarbhritya, Madan Mohan Malviya Govt Ayurveda Collage Udaipur, Rajasthan Pin Code- 313001  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashok mundotiya  madan mohan malviya govt ayurveda college udaipur  opd no 3 govt ayurveda hospital moti choatta udaipur & opd no 4 college parisar hospital radaji circle ambamata udaipur
Udaipur
RAJASTHAN 
08824119924

ashokmundotiya91926@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E669||Obesity, unspecified. Ayurveda Condition: MEDOVAHASROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: AMRITADI GUGGULU , Reference: vangsena , Route: Oral, Dosage Form: Guggulu , Dose: 7(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: honey ), Additional Information: amritadi guggulu with ruksh udvartana
2Comparator ArmDrugClassical(1) Medicine Name: Amritadi Guggulu, Reference: vangsen , Route: Oral, Dosage Form: Guggulu , Dose: 7(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: honey ), Additional Information: -
 
Inclusion Criteria  
Age From  8.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  1.Children whose parents are willing to give consent for clinical trial.
2.Children aged group from 8-16 years having clinical signs & symptoms of childhood obesity described in Ayurveda classics and modern literature.
3.Children with BMI 86th percentile - 94th percentile and above 95th percentile.
4.Childrens of both sexes will be considered in the study.
5.Children shows cardinal feature of childhood obesity will be selected.


 
 
ExclusionCriteria 
Details  1. Children aged below 7 years and above 16 years of age.
2. Children receiving drugs like steroids and anti- depressants drugs.
3. Childhood obesity due to endocrinal disorders like Cushing syndrome, hypothyroidism etc.
4. Children with BMI below 85th percentile is not considered.

 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
changes in investigation and subjective parameter  8 week  
 
Secondary Outcome  
Outcome  TimePoints 
changes in the subjective parameters  8 weeks 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study focuses on a pharmacognostical and clinical evaluation of Amritadi Guggulu and Ruksha Udvartana in managing Sthaulya (obesity) in children. The study will consist of two groups:

Group A: Participants will receive Amritadi Guggulu at a dosage of 14 mg/kg/day and Ruksha Udvartana (dry powder) applied for 20 minutes daily, either in the morning or evening on an empty stomach.

Group B: Participants will receive Amritadi Guggulu at a dosage of 14 mg/kg/day without the Ruksha Udvartana.

The trial will be conducted over a period of 8 weeks.
 
Close